[Hemolytic-uremic syndrome: varieties and particulars in the pneumococcal form; a case report].
Kuchler
Céline
C
Service de Pédiatrie Hôpital Riviera, Site du Samaritain, 1800 Vevey.
Panchard
Marc-Alain
MA
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D006463:Hemolytic-Uremic Syndrome / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D015994:Incidence; D008297:Male; D011008:Pneumococcal Infections / Q000150:complications*; D011379:Prognosis; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D019980:Amoxicillin-Potassium Clavulanate Combination; D002443:Ceftriaxone